The Permanent Commission of the Competition Council held its meeting, via videoconference, on Tuesday, January 26, 2021 at 09:30, under the chairmanship of Mr. Driss Guerraoui, President of the Competition Council.
At the beginning of the meeting, the Permanent Commission approved the minutes of its meeting held on November 27, 2020, as well as the minutes of the meeting on January 13, 2021.
After examining all aspects related to the first item on the agenda, the Permanent Commission decided to further investigate the exclusive indirect control of the company « Chedid Capital sal (Holding» through the acquisition of 80% of the share capital and voting rights of the company « Ascoma Assureurs Conseils ».
Furthermore, noting the absence of impacts on competition in the relevant national market, the Permanent Commission decided to authorize the economic concentration operation concerning the acquisition of assets of the company « Léo Pharma » by the company « Cheplapharm Arzneimittel Gmbh ».